Integrated Surgical is a Service-Disabled Veteran Owned Small Business that specializes in federal healthcare supply chain and contracting expertise, combining clinical sales and marketing.

Integrated Surgical

MedYes provides predictive and personalized medical services. The company processes and organizes patient clinical history, delivering essential information for healthcare professionals.

MedYes

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

AngioDynamics, Inc.

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

Metric
Company Name	Integrated Surgical	MedYes	AngioDynamics, Inc.	Asensus Surgical, Inc.
Symbol			ANGO	ASXC
MSH ID	COM:INTEGRATEDSURG	BR:COM:MEDYES	COM:ANGIODYNAMICS	COM:ASENSUS
Market	PRIVATE	PRIVATE	STOCKS	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare
Industry	Medical Equipment and Supplies	Healthcare Technology	Medical - Instruments & Supplies	Medical - Devices
Country	US	BR	US	US
Stage
Employee Count			815	207
Website	integratedsurg.com	medyes.com.br	angiodynamics.com	asensus.com
LinkedIn
Founders

Metric
Market Cap		224.31M	91.27M
Enterprise Value
Monthly Web Traffic	973
Web Traffic Growth	12.51
Valuation
Raised Capital

Metric
Revenue	303.91M	8.58M
Revenue (LTM)
Revenue (NTM)
Gross Profit	141.65M	-5.03M
EBITDA	-6.10M	-74.40M
Operating Income	-33.84M	-78.13M
Net Income	-184.35M	-78.43M
EPS	-4.59	-0.31
Diluted EPS	-4.59	-0.31
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.51	-0.34
Operating Profit Margin	0.04	-7.22
EBITDA Margin	-0.02	-8.67
Net Profit Margin	-0.04	-8.51
Return on Equity	-0.04	-1.10
Return on Assets	-0.03	-1.12
Return on Capital Employed	0.03	50.15

COM:INTEGRATEDSURG

Integrated Surgical

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-16.80	-0.84
P/B Ratio	0.59	1.40
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.07	11.84
EV Multiple	53.92	-0.87

Metric
Days Sales Outstanding	57.16	43.07
Days Payables Outstanding	84.64	147.66
Days Inventory Outstanding	160.40	218.03
Operating Cycle	209.74	346.59
Cash Conversion Cycle	132.21	232.56
Asset Turnover	1.00	0.26

Metric
Operating Cash Flow	-28.16M	-63.63M
Free Cash Flow	-38.94M	-64.19M
Cash Flow to Debt		-2.77
Operating Cash Flow/Sales	-0.01	-5.75
Free Cash Flow Yield	-0.03	-0.95

Metric
Cash & Equivalents	76.06M	17.10M
Accounts Receivable	7.89M	-1.18M
Inventory	60.62M	7.17M
Goodwill
Debt to Capitalization	0.03	2.24
Debt to Assets		0.08
Current Ratio	2.38	3.79
Quick Ratio	1.49	2.78

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.03	1.42
R&D to Revenue	0.10	6.58
SG&A to Revenue	0.12	3.56